129 related articles for article (PubMed ID: 2358856)
1. Rapid estimation of the proliferating index of brain tumours.
Detta A; Hitchcock E
J Neurooncol; 1990 Jun; 8(3):245-53. PubMed ID: 2358856
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.
Fukui M; Iwaki T; Sawa H; Inoue T; Takeshita I; Kitamura K
Acta Neurochir (Wien); 1986; 81(3-4):135-41. PubMed ID: 3529838
[TBL] [Abstract][Full Text] [Related]
4. Cell-kinetic characteristics of human brain tumors.
Assietti R; Butti G; Magrassi L; Danova M; Riccardi A; Gaetani P
Oncology; 1990; 47(4):344-51. PubMed ID: 2367061
[TBL] [Abstract][Full Text] [Related]
5. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
6. Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours.
Gungor F; Bezircioglu H; Guvenç G; Tezcan M; Yildiz A; Uluc E; Isisag A
Nucl Med Commun; 2000 Sep; 21(9):803-10. PubMed ID: 11065152
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
Hoshino T; Ito S; Asai A; Shibuya M; Prados MD; Dodson BA; Davis RL; Wilson CB
Int J Cancer; 1992 Jan; 50(1):1-5. PubMed ID: 1728598
[TBL] [Abstract][Full Text] [Related]
8. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced meningiomas and their proliferative activity. Cytokinetic study using bromodeoxyuridine.
Tashima T; Fukui M; Nishio S; Fujii K; Iwaki T
Acta Neurochir (Wien); 1990; 102(1-2):69-72. PubMed ID: 2305653
[TBL] [Abstract][Full Text] [Related]
10. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods.
Morimura T; Kitz K; Stein H; Budka H
J Neurooncol; 1991 Feb; 10(1):1-11. PubMed ID: 2022970
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.
Nagashima T; DeArmond SJ; Murovic J; Hoshino T
Acta Neuropathol; 1985; 67(1-2):155-9. PubMed ID: 2992212
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
13. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling.
Parkins CS; Darling JL; Gill SS; Revesz T; Thomas DG
Br J Neurosurg; 1991; 5(3):289-98. PubMed ID: 1892572
[TBL] [Abstract][Full Text] [Related]
15. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
[TBL] [Abstract][Full Text] [Related]
16. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
17. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
Zuber P; Hamou MF; de Tribolet N
Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
[TBL] [Abstract][Full Text] [Related]
18. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
Nakasu S; Nakajima M; Nioka H; Matsumura K; Handa J
Neurol Med Chir (Tokyo); 1994 May; 34(5):269-73. PubMed ID: 7519746
[TBL] [Abstract][Full Text] [Related]
20. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]